世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000038595

抗生物質の世界市場(2024-2028)

TechNavio

Global antibiotics market 2024-2028

発刊日 2024/05/17

言語英語

体裁PDF/170ページ

ライセンス/価格170ページ

0000038595

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

抗生物質市場は2023年から2028年に166億3,130万米ドルの成長が見込まれ、予測期間中のCAGRは5.67%で成長すると予測されます。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場は、感染症の流行の高まり、様々な疾患とその治療に対する意識の高まり、特別な規制指定によって牽引されています。

調査範囲

  • 市場セグメント
    ➣ 製品別
      ◇ 広域スペクトル抗生物質
      ◇ 狭域スペクトル抗生物質
    ➣ 投与経路別
      ◇ 静脈内
      ◇ 経口
      ◇ その他
    ➣ 地域別
      ◇ アジア
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ 世界のその他の地域

本調査では、今後数年間の抗生物質市場成長を牽引する主要因の1つとして、戦略的提携やM&A(合併・買収)を挙げています。また、患者支援プログラム(PAP)の存在や、抗生物質研究のための連邦政府や機関への資金提供の増加は、市場の大きな需要につながります。

抗生物質市場に関するレポートは、次の分野をカバーしています。

  • 抗生物質市場の規模
  • 抗生物質市場の予測
  • 抗生物質市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。

  • 調査企業
    ➣ Abbott Laboratories
    ➣ AbbVie Inc.
    ➣ Armata Pharmaceuticals Inc.
    ➣ Aspen Pharmacare Holdings Ltd.
    ➣ Astellas Pharma Inc.
    ➣ Aurobindo Pharma Ltd.
    ➣ Bayer AG
    ➣ F. Hoffmann La Roche Ltd.
    ➣ Flynn Pharma Ltd.
    ➣ GlaxoSmithKline Plc
    ➣ Incepta Pharmaceuticals Ltd.
    ➣ Johnson and Johnson Services Inc.
    ➣ Lupin Ltd.
    ➣ Mayne Pharma Group Ltd.
    ➣ Melinta Therapeutics LLC
    ➣ Merck KGaA
    ➣ Pfizer Inc.
    ➣ Sanofi SA
    ➣ 武田製薬工業(Takeda Pharmaceutical Co. Ltd.)
    ➣ Teva Pharmaceutical Industries Ltd.

また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Market Segmentation by Route of Administration
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global Antibiotics Market 2018 - 2022
Historic Market Size - Data Table on Global Antibiotics Market 2018 - 2022 ($ million)
4.2 Product segment analysis 2018 - 2022
Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 Route of Administration segment analysis 2018 - 2022
Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product
6.1 Market segments
Chart on Product - Market share 2023-2028 (%)
Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Chart on Comparison by Product
Data Table on Comparison by Product
6.3 Broad-spectrum antibiotics - Market size and forecast 2023-2028
Chart on Broad-spectrum antibiotics - Market size and forecast 2023-2028 ($ million)
Data Table on Broad-spectrum antibiotics - Market size and forecast 2023-2028 ($ million)
Chart on Broad-spectrum antibiotics - Year-over-year growth 2023-2028 (%)
Data Table on Broad-spectrum antibiotics - Year-over-year growth 2023-2028 (%)
6.4 Narrow-spectrum antibiotics - Market size and forecast 2023-2028
Chart on Narrow-spectrum antibiotics - Market size and forecast 2023-2028 ($ million)
Data Table on Narrow-spectrum antibiotics - Market size and forecast 2023-2028 ($ million)
Chart on Narrow-spectrum antibiotics - Year-over-year growth 2023-2028 (%)
Data Table on Narrow-spectrum antibiotics - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Product
Market opportunity by Product ($ million)
Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Route of Administration
7.1 Market segments
Chart on Route of Administration - Market share 2023-2028 (%)
Data Table on Route of Administration - Market share 2023-2028 (%)
7.2 Comparison by Route of Administration
Chart on Comparison by Route of Administration
Data Table on Comparison by Route of Administration
7.3 Intravenous - Market size and forecast 2023-2028
Chart on Intravenous - Market size and forecast 2023-2028 ($ million)
Data Table on Intravenous - Market size and forecast 2023-2028 ($ million)
Chart on Intravenous - Year-over-year growth 2023-2028 (%)
Data Table on Intravenous - Year-over-year growth 2023-2028 (%)
7.4 Oral - Market size and forecast 2023-2028
Chart on Oral - Market size and forecast 2023-2028 ($ million)
Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Chart on Oral - Year-over-year growth 2023-2028 (%)
Data Table on Oral - Year-over-year growth 2023-2028 (%)
7.5 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Route of Administration
Market opportunity by Route of Administration ($ million)
Data Table on Market opportunity by Route of Administration ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.4 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.5 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 India - Market size and forecast 2023-2028
Chart on India - Market size and forecast 2023-2028 ($ million)
Data Table on India - Market size and forecast 2023-2028 ($ million)
Chart on India - Year-over-year growth 2023-2028 (%)
Data Table on India - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ million)
Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business

12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Abbott Laboratories
Abbott Laboratories - Overview
Abbott Laboratories - Business segments
Abbott Laboratories - Key news
Abbott Laboratories - Key offerings
Abbott Laboratories - Segment focus
12.4 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
12.5 Aspen Pharmacare Holdings Ltd
Aspen Pharmacare Holdings Ltd - Overview
Aspen Pharmacare Holdings Ltd - Business segments
Aspen Pharmacare Holdings Ltd - Key offerings
Aspen Pharmacare Holdings Ltd - Segment focus
12.6 Astellas Pharma Inc.
Astellas Pharma Inc. - Overview
Astellas Pharma Inc. - Product / Service
Astellas Pharma Inc. - Key news
Astellas Pharma Inc. - Key offerings
12.7 Aurobindo Pharma Ltd.
Aurobindo Pharma Ltd. - Overview
Aurobindo Pharma Ltd. - Product / Service
Aurobindo Pharma Ltd. - Key offerings
12.8 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key offerings
Bayer AG - Segment focus
12.9 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
12.10 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
12.11 Incepta Pharmaceuticals Ltd.
Incepta Pharmaceuticals Ltd. - Overview
Incepta Pharmaceuticals Ltd. - Product / Service
Incepta Pharmaceuticals Ltd. - Key offerings
12.12 Johnson and Johnson
Johnson and Johnson - Overview
Johnson and Johnson - Business segments
Johnson and Johnson - Key news
Johnson and Johnson - Key offerings
Johnson and Johnson - Segment focus
12.13 Lupin Ltd.
Lupin Ltd. - Overview
Lupin Ltd. - Product / Service
Lupin Ltd. - Key news
Lupin Ltd. - Key offerings
12.14 Mayne Pharma Group Ltd.
Mayne Pharma Group Ltd. - Overview
Mayne Pharma Group Ltd. - Business segments
Mayne Pharma Group Ltd. - Key news
Mayne Pharma Group Ltd. - Key offerings
Mayne Pharma Group Ltd. - Segment focus
12.15 Merck KGaA
Merck KGaA - Overview
Merck KGaA - Business segments
Merck KGaA - Key news
Merck KGaA - Key offerings
Merck KGaA - Segment focus
12.16 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
12.17 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Antibiotics Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Product - Market share 2023-2028 (%)
Exhibits33: Data Table on Product - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Product
Exhibits35: Data Table on Comparison by Product
Exhibits36: Chart on Broad-spectrum antibiotics - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on Broad-spectrum antibiotics - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on Broad-spectrum antibiotics - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Broad-spectrum antibiotics - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Narrow-spectrum antibiotics - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Narrow-spectrum antibiotics - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Narrow-spectrum antibiotics - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Narrow-spectrum antibiotics - Year-over-year growth 2023-2028 (%)
Exhibits44: Market opportunity by Product ($ million)
Exhibits45: Data Table on Market opportunity by Product ($ million)
Exhibits46: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits47: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits48: Chart on Comparison by Route of Administration
Exhibits49: Data Table on Comparison by Route of Administration
Exhibits50: Chart on Intravenous - Market size and forecast 2023-2028 ($ million)
Exhibits51: Data Table on Intravenous - Market size and forecast 2023-2028 ($ million)
Exhibits52: Chart on Intravenous - Year-over-year growth 2023-2028 (%)
Exhibits53: Data Table on Intravenous - Year-over-year growth 2023-2028 (%)
Exhibits54: Chart on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits55: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits56: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits58: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits59: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits60: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits61: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits62: Market opportunity by Route of Administration ($ million)
Exhibits63: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits65: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits66: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits67: Chart on Geographic comparison
Exhibits68: Data Table on Geographic comparison
Exhibits69: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits102: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits103: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits105: Market opportunity By Geographical Landscape ($ million)
Exhibits106: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits107: Impact of drivers and challenges in 2023 and 2028
Exhibits108: Overview on criticality of inputs and factors of differentiation
Exhibits109: Overview on factors of disruption
Exhibits110: Impact of key risks on business
Exhibits111: Companies covered
Exhibits112: Matrix on companies position and classification
Exhibits113: Abbott Laboratories - Overview
Exhibits114: Abbott Laboratories - Business segments
Exhibits115: Abbott Laboratories - Key news
Exhibits116: Abbott Laboratories - Key offerings
Exhibits117: Abbott Laboratories - Segment focus
Exhibits118: AbbVie Inc. - Overview
Exhibits119: AbbVie Inc. - Product / Service
Exhibits120: AbbVie Inc. - Key news
Exhibits121: AbbVie Inc. - Key offerings
Exhibits122: Aspen Pharmacare Holdings Ltd - Overview
Exhibits123: Aspen Pharmacare Holdings Ltd - Business segments
Exhibits124: Aspen Pharmacare Holdings Ltd - Key offerings
Exhibits125: Aspen Pharmacare Holdings Ltd - Segment focus
Exhibits126: Astellas Pharma Inc. - Overview
Exhibits127: Astellas Pharma Inc. - Product / Service
Exhibits128: Astellas Pharma Inc. - Key news
Exhibits129: Astellas Pharma Inc. - Key offerings
Exhibits130: Aurobindo Pharma Ltd. - Overview
Exhibits131: Aurobindo Pharma Ltd. - Product / Service
Exhibits132: Aurobindo Pharma Ltd. - Key offerings
Exhibits133: Bayer AG - Overview
Exhibits134: Bayer AG - Business segments
Exhibits135: Bayer AG - Key offerings
Exhibits136: Bayer AG - Segment focus
Exhibits137: F. Hoffmann La Roche Ltd. - Overview
Exhibits138: F. Hoffmann La Roche Ltd. - Business segments
Exhibits139: F. Hoffmann La Roche Ltd. - Key news
Exhibits140: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits141: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits142: GlaxoSmithKline Plc - Overview
Exhibits143: GlaxoSmithKline Plc - Business segments
Exhibits144: GlaxoSmithKline Plc - Key news
Exhibits145: GlaxoSmithKline Plc - Key offerings
Exhibits146: GlaxoSmithKline Plc - Segment focus
Exhibits147: Incepta Pharmaceuticals Ltd. - Overview
Exhibits148: Incepta Pharmaceuticals Ltd. - Product / Service
Exhibits149: Incepta Pharmaceuticals Ltd. - Key offerings
Exhibits150: Johnson and Johnson - Overview
Exhibits151: Johnson and Johnson - Business segments
Exhibits152: Johnson and Johnson - Key news
Exhibits153: Johnson and Johnson - Key offerings
Exhibits154: Johnson and Johnson - Segment focus
Exhibits155: Lupin Ltd. - Overview
Exhibits156: Lupin Ltd. - Product / Service
Exhibits157: Lupin Ltd. - Key news
Exhibits158: Lupin Ltd. - Key offerings
Exhibits159: Mayne Pharma Group Ltd. - Overview
Exhibits160: Mayne Pharma Group Ltd. - Business segments
Exhibits161: Mayne Pharma Group Ltd. - Key news
Exhibits162: Mayne Pharma Group Ltd. - Key offerings
Exhibits163: Mayne Pharma Group Ltd. - Segment focus
Exhibits164: Merck KGaA - Overview
Exhibits165: Merck KGaA - Business segments
Exhibits166: Merck KGaA - Key news
Exhibits167: Merck KGaA - Key offerings
Exhibits168: Merck KGaA - Segment focus
Exhibits169: Pfizer Inc. - Overview
Exhibits170: Pfizer Inc. - Product / Service
Exhibits171: Pfizer Inc. - Key news
Exhibits172: Pfizer Inc. - Key offerings
Exhibits173: Sanofi SA - Overview
Exhibits174: Sanofi SA - Business segments
Exhibits175: Sanofi SA - Key news
Exhibits176: Sanofi SA - Key offerings
Exhibits177: Sanofi SA - Segment focus
Exhibits178: Inclusions checklist
Exhibits179: Exclusions checklist
Exhibits180: Currency conversion rates for US$
Exhibits181: Research methodology
Exhibits182: Information sources
Exhibits183: Data validation
Exhibits184: Validation techniques employed for market sizing
Exhibits185: Data synthesis
Exhibits186: 360 degree market analysis
Exhibits187: List of abbreviations

この商品のレポートナンバー

0000038595

TOP